Table 1.
With metabolic syndrome (n=49) | Without metabolic syndrome (n=71) | P value | |
---|---|---|---|
Age (years) | 42.7±6.5 | 39.2±6.7 | 0.005 |
Sex (M/F) (n) | 14/35 | 14/57 | 0.261 |
Race (white/black/other) (n) | 22/22/5 | 19/49/3 | 0.027 |
Body weight (kg) | 108±20.7 | 107±20.2 | 0.830 |
BMI (kg/m2) | 38.5±6.2 | 38.5±6.4 | 0.953 |
Waist circumference (all) (cm) | 114.4±11.7 | 113.3±14.1 | 0.634 |
Neck circumference (cm) | 40.1±3.8 | 38.5±3.8 | 0.026 |
Lean body mass (kg) | 63.1±12.9 | 59.6±11.1 | 0.134 |
Body fat (%) | 39.8±6.9 | 42.2±6.9 | 0.078 |
Visceral fat (cm3) | 395.5±151.5 | 298.6±160.3 | 0.002 |
Subcutaneous fat (cm3) | 872.0±315.2 | 952.3±302.3 | 0.160 |
Systolic blood pressure (mmHg) | 128.7±12.4 | 120.8±11.3 | <0.001 |
Diastolic blood pressure (mmHg) | 76.3±10.1 | 72.5±9.4 | 0.034 |
Fasting glucose (mg/dL) | 94.7±16.2 | 86.6±8.1 | 0.002 |
Fasting insulin (mU/L) | 12.8±7.2 | 9.8±7.2 | 0.027 |
HOMA index | 3.0±1.9 | 2.1±1.7 | 0.002 |
Triglycerides (mg/dL) | 121.9±65.0 | 81.7±36.7 | <0.001 |
Total cholesterol (mg/dL) | 181.9±43.9 | 178.5±39.2 | 0.618 |
HDL-C (all) (mg/dL) | 43.2±6.8 | 54.4±14.0 | <0.001 |
HDL-C (men) (mg/dL) | 42.4±7.6 (n=14) | 48.8±9.4 (n=14) | 0.031 |
HDL-C (women) (mg/dL) | 43.5±6.5 (n=35) | 55.8±14.6 (n=57) | <0.001 |
LDL-C (mg/dL) | 118.1±37.1 | 110.0±26.5 | 0.162 |
Metabolic syndrome score | 24.0±8.7 | 15.9±5.7 | <0.001 |
Current smoker (Y/N/Unknown) (n) | 3/44/2 | 7/56/8 | 0.260 |
Medications (n) | |||
Psychiatric | 1 | 5 | 0.416a |
Antidiabetic | 3 | 0 | 0.131a |
Anti-inflammatory | 4 | 4 | 0.850a |
Statins | 4 | 3 | 0.601a |
Antihypertensive | 12 | 15 | 0.829a |
Intranasal steroids | 4 | 4 | 0.850a |
Oral contraceptives (women only) | 1 | 7 | 0.183a |
Chi-squared test P value.
Significant P values are in bold.
BMI, body mass index; HOMA, homeostasis model assessment; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.